Rowbotham et al.
2011
Oral and cutaneous thermosensory profile of selective TRPV1 inhibition by ABT-102 in a randomized healthy volunteer trial
US20120135918A1
(en )
2012-05-31
Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
JP5579858B2
(ja )
2014-08-27
トラマドール及びセレコキシブを含む疼痛治療用組成物
JP6124986B2
(ja )
2017-05-10
拡張期心不全を処置するための増殖分化因子(gdf)
TW200510349A
(en )
2005-03-16
Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
JP2006515351A
(ja )
2006-05-25
摂食行動の修正
JP2014208675A
(ja )
2014-11-06
満腹ホルモン放出の刺激
JP2004524340A
(ja )
2004-08-12
非ニューロパシー炎症性疼痛を治療するための化合物のペプチドクラスの新規の使用
JP2007506752A
(ja )
2007-03-22
肺動脈高血圧症を治療するための併用療法におけるイロプロスト
TW200914040A
(en )
2009-04-01
Compositions and methods for increasing vascularization
KINNEY et al.
1982
The treatment of severe Raynaud's phenomenon with verapamil
Yagi et al.
1997
Intramedullary spinal cord tumour associated with neurofibromatosis type 1
JP2004340957A5
(https= )
2007-06-14
WO1998007445A1
(en )
1998-02-26
Preventive/remedy for frequent urination and urinary incontinence
JP2006515632A
(ja )
2006-06-01
ストレプトリジンoの投与により状態を治療する方法
US11219668B2
(en )
2022-01-11
Method of treating a vasculopathy in a human subject
US6376513B1
(en )
2002-04-23
Drug for relieving pain and promoting the removal of calculi in urolithiasis
JP2005523270A5
(https= )
2006-03-30
Onaga et al.
1998
Pituitary adenylate cyclase-activating polypeptide (PACAP) induces duodenal phasic contractions via the vagal cholinergic nerves in sheep
US20150368220A1
(en )
2015-12-24
Pharmaceutical composition for treating or preventing stress urinary incontinence or mixed urinary incontinence, and method for screening compound comprised in said pharmaceutical composition
Azriel et al.
2001
Characterization and autoradiographic localization of neurotensin binding sites in human sigmoid colon
JP2004073182A5
(https= )
2006-06-29
WO2011019399A1
(en )
2011-02-17
Preservation of blood vessels using phosphodiesterase inhibitors
Jerde et al.
1999
NK‐2 is the predominant tachykinin receptor subtype in the swine ureter
EP2344176A1
(en )
2011-07-20
Use of bradykinin b1 receptor antagonists in intestinal fibrosis treatment